Qube Research & Technologies (QRT)’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$917K Sell
10,000
-24,200
-71% -$2.12M ﹤0.01% 2447
2026
Q1
$2.91M Sell
34,200
-31,400
-48% -$2.8M ﹤0.01% 1951
2025
Q4
$5.18M Buy
65,600
+6,300
+11% +$494K 0.01% 1753
2025
Q3
$4.74M Buy
59,300
+37,800
+176% +$3.22M ﹤0.01% 1785
2025
Q2
$1.95M Buy
21,500
+20,900
+3,483% +$1.91M ﹤0.01% 2202
2025
Q1
$56.2K Sell
600
-900
-60% -$80.6K ﹤0.01% 3103
2024
Q4
$136K Buy
1,500
+100
+7% +$9.54K ﹤0.01% 2925
2024
Q3
$145K Buy
+1,400
New +$143K ﹤0.01% 2678

Other funds holding CL

Qube Research & Technologies (QRT)'s CL Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Colgate-Palmolive (CL) stake by 72% in Q2 2026, selling an estimated $153M and leaving 669,266 shares worth $61.4M. The position accounts for 0.06% of the portfolio, ranked #430.

Qube Research & Technologies (QRT) first reported a position in CL in Q1 2018 and has held it in 28 quarters since. The position peaked at $406M in Q1 2025. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Qube Research & Technologies (QRT) held 669,266 shares of Colgate-Palmolive worth $61.4M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 1,752,027 Colgate-Palmolive shares in Q2 2026, an estimated $153M.
  • Colgate-Palmolive made up 0.06% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #430 holding.
  • Qube Research & Technologies (QRT) first reported a position in Colgate-Palmolive in Q1 2018 and has held it in 28 quarters since.
  • Qube Research & Technologies (QRT)'s Colgate-Palmolive position peaked at $406M in Q1 2025.
  • 2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.